For stage 3 BC, the expression of LincRNA-BC4 is significantly low, whereas the expression of lincRNA-BC5 is significantly high, and the expression of lincRNA-BC2 has significant positive correlations with LNM (lymph node metastasis). Here, CHMP2A is linked to breast cancer.